Inventor
NANTERMET PHILIPPE G
US37 patents
⚠️ This page may combine multiple inventors who share the name “NANTERMET PHILIPPE G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
11 patentsUS7348448B2Mar 25, 2008
Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
MERCK & CO INC28 citations90
US6403612B2Jun 11, 2002
Thrombin receptor antagonists
MERCK & CO INC9 citations74
US6515011B2Feb 4, 2003
Thrombin inhibitors
MERCK & CO INC11 citations72
US6544982B1Apr 8, 2003
Thrombin receptor antagonists
MERCK & CO INC5 citations63
US7144899B2Dec 5, 2006
Thrombin inhibitors
MERCK & CO INC5 citations62
US7354942B2Apr 8, 2008
Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
MERCK & CO INC3 citations61
US6515023B2Feb 4, 2003
Thrombin receptor antagonists
MERCK & CO INC6 citations60
US7550481B2Jun 23, 2009
Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease
MERCK & CO INC2 citations52
US7084134B2Aug 1, 2006
Thrombin inhibitors
MERCK & CO INC0 citations52
US6339090B1Jan 15, 2002
Alpha 1A adrenergic receptor antagonists
MERCK & CO INC1 citations52
US7026324B2Apr 11, 2006
Thrombin inhibitors
MERCK & CO INC0 citations41
SCRIPPS RESEARCH INST
8 patentsUS5461169AOct 24, 1995
Total synthesis of taxol and taxol analogs
SCRIPPS RESEARCH INST33 citations92
US5440057AAug 8, 1995
Access to taxol analogs
SCRIPPS RESEARCH INST31 citations92
US5504222AApr 2, 1996
Transformations of taxol
SCRIPPS RESEARCH INST9 citations73
US5481007AJan 2, 1996
Taxoid synthesis
SCRIPPS RESEARCH INST11 citations72
US6043382AMar 28, 2000
Transformations of taxol
SCRIPPS RESEARCH INST3 citations62
US5786489AJul 28, 1998
Transformations of taxol
SCRIPPS RESEARCH INST2 citations62
US5750691AMay 12, 1998
Access to taxol analogs
SCRIPPS RESEARCH INST2 citations62
US5760240AJun 2, 1998
Taxoid synthesis
SCRIPPS RESEARCH INST2 citations58
MERCK SHARP & DOHME
7 patentsUS10968210B2Apr 6, 2021
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME0 citations51
US8008315B2Aug 30, 2011
Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
MERCK SHARP & DOHME0 citations49
US7816378B2Oct 19, 2010
Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease
MERCK SHARP & DOHME0 citations42
US7968571B2Jun 28, 2011
2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's Disease
MERCK SHARP & DOHME0 citations41
US7820674B2Oct 26, 2010
Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
MERCK SHARP & DOHME0 citations41
US7951949B2May 31, 2011
Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of Alzheimer's disease
MERCK SHARP & DOHME0 citations40
US7678783B2Mar 16, 2010
Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
MERCK SHARP & DOHME0 citations37
NANTERMET PHILIPPE G
3 patentsUS8399473B2Mar 19, 2013
Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
NANTERMET PHILIPPE G0 citations36
US8394837B2Mar 12, 2013
2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
NANTERMET PHILIPPE G0 citations34
US9073879B2Jul 7, 2015
Oxazole derivatives useful as modulators of FAAH
NANTERMET PHILIPPE G0 citations33
MERCK SHARP & DOHME INC
2 patentsUS7829597B2Nov 9, 2010
Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
MERCK SHARP & DOHME INC0 citations44
US7847100B2Dec 7, 2010
1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
MERCK SHARP & DOHME INC0 citations35